Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status. (Q42632056)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 2004

Language	Label	Description	Also known as
English	Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status.	scientific article published on August 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15272916%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15272916%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Roberto Attanasio

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15272916%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Renato Cozzi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15272916%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sandro Lodrini

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15272916%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Giovanni Lasio

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15272916%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15272916%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15272916%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

61

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15272916%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15272916%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

209-215

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15272916%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

GH/IGF-I normalization and tumor shrinkage during long-term treatment of acromegaly by lanreotide.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02082.X

21 January 2018

Lanreotide 60 mg, a New Long-Acting Formulation: Effectiveness in the Chronic Treatment of Acromegaly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02082.X

21 January 2018

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02082.X

21 January 2018

Growth-hormone and prolactin excess

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02082.X

21 January 2018

Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02082.X

21 January 2018

Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02082.X

21 January 2018

Criteria for cure of acromegaly: a consensus statement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02082.X

21 January 2018

In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02082.X

21 January 2018

Efficacy of combined treatment with lanreotide and cabergoline in selected therapy-resistant acromegalic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02082.X

21 January 2018

Guidelines for acromegaly management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02082.X

21 January 2018

Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02082.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2004.02082.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15272916%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15272916%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42632056&oldid=1576816084"